UTI Long (India) Manager Performance Evaluation

F00000PDLD -- India Fund  

INR 25.07  0.14  0.56%

The entity has beta of -0.3927 which indicates as returns on market increase, returns on owning UTI Long are expected to decrease at a much smaller rate. During bear market, UTI Long is likely to outperform the market.. Although it is extremely important to respect UTI Long Term current price movements, it is better to be realistic regarding the information on equity historical returns. The way in which we are measuring future performance of any fund is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By evaluating UTI Long Term technical indicators you can currently evaluate if the expected return of 0.0% will be sustainable into the future.
Horizon     30 Days    Login   to change

UTI Long Term Relative Risk vs. Return Landscape

If you would invest  2,507  in UTI Long Term Equity Dir Div on August 20, 2018 and sell it today you would earn a total of  0.00  from holding UTI Long Term Equity Dir Div or generate 0.0% return on investment over 30 days. UTI Long Term Equity Dir Div is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than UTI Long Term Equity Dir Div and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

UTI Long Current Valuation

Not valued
September 19, 2018
25.07
Market Value
0.00
Real Value
Target Odds
  
0.00
Upside
UTI Long is Unknown risk asset. UTI Long Term current Real Value cannot be determined due to lack of data. The regular price of UTI Long Term is 25.07. Based on Macroaxis valuation methodology, the fund cannot be evaluated at this time. We determine the value of UTI Long Term from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point in time securities prices and their ongoing real values will draw towards each other.

UTI Long Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
F00000PDLD
Based on monthly moving average UTI Long is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UTI Long by adding it to a well-diversified portfolio.

UTI Long Performance Rating

UTI Long Term Equity Dir Div Risk Adjusted Performance Analysis

0 

Risk-Adjusted Fund Performance

Over the last 30 days UTI Long Term Equity Dir Div has generated negative risk-adjusted returns adding no value to fund investors.

UTI Long Alerts

Equity Alerts and Improvement Suggestions

UTI Long Term generates negative expected return over the last 30 days
Latest headline from postanalyst.com: Investors Jumping Ship on Hologic, Inc. , Wipro Limited
The fund retains about 5.94% of its assets under management (AUM) in cash

UTI Long Performance Indicators

UTI Long Term Basic Price Performance Measures

Fifty Two Week Low23.6521
Fifty Two Week High27.2473
Annual Report Expense Ratio1.87%
Additionally see Investing Opportunities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com